2017 International Congress Archives - Page 140 of 155

The influence of LRRK2 mutations on cholinergic system in manifest and prodromal stage of Parkinson’s disease: a positron emission tomography study

S. [email protected], D. Wile, J. Fu, J. Valerio, E. Shahinfard, S. McCormick, R. Mabrouk, N. Vafai, J. McKenzie, N. Neilson, A. Perez-Soriano, J. Arena, M. Cherkasova, J. Zhang, C. Zabetian, J. Aasly, Z. Wszolek, M. McKeown, V. Sossi, A. Stoessl (Beijing, China)
The influence of neurorehabilitation on Parkinson medication

V. Tomantschger, A. Tautscher-Basnett, M. Freimueller (Hermagor, Austria)
The influence of sleep disordered breathing in REM sleep behavior disorder associated symptoms

P. Bugalho, M. Mendonça, M. Salavisa, R. Barbosa (Lisbon, Portugal)
The involvement of primary olfactory cortex in olfactory deficits in early-stage Parkinson’s disease

J. Wang, T. Subramanian, Q. Yang (Hershey, PA, USA)
The landscape of interventional trials in Parkinson disease: A 10-year review of ClinicalTrials.gov between 2006 and 2016

K. Wyant, E. Yasuda, V. Kotagal (Ann Arbor, MI, USA)
The Life Style and Risk of Parkinson Disease

R. Pinzon (Yogyakarta, Indonesia)
The Long-Term Safety of Deutetrabenazine for Chorea in Huntington Disease

S. Frank, C. Vaughan, D. Stamler, D. Oakes, M. Davis, S. Eberly, E. Kayson, J. Whaley, J. Goldstein, C. Testa (Boston, MA, USA)
The management of Parkinson’s disease in the Middle East countries: the MDS-middle east task force survey

H. Khalil, Z. Aldaajani, S. Baudry, M. Abualmelh, T. Mohammad, M. Salari, M. Bhatt, S. Tabbal, N.A. Syed, B. Jeon, C. Goetz, J.A. Bajwa (Irbid, Jordan)
The nature of postural tremor in Parkinson’s disease

M. Dirkx, H. Zach, M. Hallet, R. Helmich (Nijmegen, Netherlands)
The neural correlates of apathy in premanifest and manifest Huntington’s disease: A cross-sectional multimodal imaging study

S. Martinez-Horta, J. Perez-Perez, F. Sampedro, M. Carceller, A. Horta-Barba, J. Pagonabarraga, J. Kulisevsky (Barcelona, Spain)